Alexis A Thompson

  • 9637 Citations
1993 …2022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Alexis Thompson is currently the Hematology Section Head at Ann and Robert H. Lurie Children’s Hospital of Chicago in Chicago, Illinois. She holds the A. Watson and Sarah Armour Endowed Chair for Blood Diseases and Cancer at Lurie Children’s. She is also a Professor of Pediatrics at the Northwestern University Feinberg School of Medicine. Dr. Thompson is also the Associate Director for Equity and Minority Health at the Robert H. Lurie Cancer Center and Northwestern University Feinberg School of Medicine. She has served on regional and national on advisory committees for governmental agencies as well as non-profit organizations focused on improving healthcare access, increasing workforce diversity and reducing health disparities. Currently she is President of the American Society of Hematology.

In her current position, she is an investigator on multi-center trials and as well as her own institutional clinical studies in thalassemia, sickle cell disease and ITP. Her most significant scientific contributions are clinical and translation studies to better understand and treat hemoglobinopathies. She has been a leader in multicenter collaborations, such as the NHLBI-funded Thalassemia Clinical Research Network and the Sickle Cell Disease Implementation Consortium.

Her clinical interests include hemoglobinopathies (thalassemia and sickle cell disease), bone marrow failure syndromes and stem cell transplantation in pediatric patients.

Certifications and Licenses

Pediatric Hematology-Oncology

Training Experience

1986Residency, Children's Hospital, Los Angeles
1990Fellowship, Children's Hospital of Philadelphia

Education/Academic qualification

MPH, University of California-Los Angeles

… → 1987

MD, Tulane University

… → 1983

Fingerprint Dive into the research topics where Alexis A Thompson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Sickle Cell Anemia Medicine & Life Sciences
Thalassemia Medicine & Life Sciences
Young Adult Medicine & Life Sciences
Sickle Cell Trait Medicine & Life Sciences
Iron Medicine & Life Sciences
Hydroxyurea Medicine & Life Sciences
Iron Overload Medicine & Life Sciences
Hemophilia A Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2012 2022

Research Output 1993 2019

Combination Oral Chelation in Adult Patients with Transfusion-dependent Thalassemia and High Iron Burden

Hammond, J., Thompson, A. A., Fogel, M. A., Hammond, K., Kokroko, J. & Kwiatkowski, J. L., Jan 1 2019, In : Journal of pediatric hematology/oncology. 41, 1, p. E47-E50

Research output: Contribution to journalArticle

Chelation Therapy
Iron Overload

Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes

for the Joint Outcome Study Group Investigators, Jan 1 2019, In : Haemophilia.

Research output: Contribution to journalArticle

Factor VIII
Hemophilia A
Outcome Assessment (Health Care)
3 Citations (Scopus)

Prevalence and management of iron overload in pyruvate kinase deficiency: Report from the Pyruvate Kinase Deficiency Natural History Study

Van Beers, E. J., Van Straaten, S., Morton, D. H., Barcellini, W., Eber, S. W., Glader, B., Yaish, H. M., Chonat, S., Kwiatkowski, J. L., Rothman, J. A., Sharma, M., Neufeld, E. J., Sheth, S., Despotovic, J. M., Kollmar, N., Pospíšilová, D., Knoll, C. M., Kuo, K., Pastore, Y. D., Thompson, A. A. & 17 others, Newburger, P. E., Ravindranath, Y., Wang, W. C., Wlodarski, M. W., Wang, H., Holzhauer, S., Breakey, V. R., Verhovsek, M., Kunz, J., McNaull, M. A., Rose, M. J., Bradeen, H. A., Addonizio, K., Li, A., Al-Sayegh, H., London, W. B. & Grace, R. F., Jan 31 2019, In : Haematologica. 104, 2, p. e51-e53

Research output: Contribution to journalLetter

Iron Overload
Natural History
Pyruvate Kinase Deficiency of Red Cells

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study

Cronin, R. M., Hankins, J. S., Byrd, J., Pernell, B. M., Kassim, A., Adams-Graves, P., Thompson, A. A., Kalinyak, K., DeBaun, M. & Treadwell, M., Dec 1 2019, In : Hematology (Amsterdam, Netherlands). 24, 1, p. 189-198 10 p.

Research output: Contribution to journalArticle

Open Access
Sickle Cell Anemia
Appointments and Schedules
1 Citation (Scopus)
Sickle Cell Anemia
Quality of Life
Chronic Disease
Cross-Sectional Studies